Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2260150

CCCCCCCCCCCCC(C)C(C)(Cl)CCC[Si](OC)(OC)OC.N

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170189318-A1 Skin, Nail and Hair Topical Antimicrobial Methods Using Formulations Containing Organosilane Quaternaries AP GOLDSHIELD LLC 2017-07-06 US claimed
US-20160128333-A1 ANTIMICROBIAL QUATERNARY AMMONIUM ORGANOSILANE COATINGS QORE SYSTEMS 2016-05-12 US claimed
WO-2013110614-A1 METHOD FOR CLEANING A LAUNDRY WASHING MACHINE AND LAUNDRY WASHING MACHINE IMPLEMENTING THE METHOD ELECTROLUX HOME PRODUCTS CORPORATION N.V. (BE) 2013-08-01 WO claimed
EP-2620536-A1 Method for cleaning a laundry washing machine and laundry washing machine implementing the method Electrolux Home Products Corporation N.V. (BE) 2013-07-31 EP claimed
WO-2011123623-A2 SKIN, NAIL AND HAIR TOPICAL ANTIMICROBIAL METHODS USING FORMULATIONS CONTAINING ORGANOSILANE QUATERNARIES AP GOLDSHIELD, LLC (US) 2011-10-06 WO claimed
EP-1628639-A4 ANTIMICROBIAL QUATERNARY AMMONIUM ORGANOSILANE COATINGS COATING SYSTEMS LAB INC (US) 2007-05-02 EP claimed
EP-1628639-A2 ANTIMICROBIAL QUATERNARY AMMONIUM ORGANOSILANE COATINGS Coating Systems Laboratories, Inc. (US) 2006-03-01 EP claimed
US-20050008613-A1 Antimicrobial quaternary ammonium organosilane coatings COATING SYSTEMS LABORATORIES, INC. 2005-01-13 US claimed
WO-2004105687-A2 ANTIMICROBIAL QUATERNARY AMMONIUM ORGANOSILANE COATINGS COATING SYSTEMS LABORATORIES, INC. (US) 2004-12-09 WO claimed
US-6613755-B2 Disinfecting skin, hair or nails with water soluble compound such as 3-(trimethoxysilyl)propyloctadecyldimethyl ammonium chloride or 3-(trimethoxysilyl)propyldidecylmethyl ammonium chloride COATING SYSTEMS LABORATORIES, INC. 2003-09-02 US claimed
US-20020141959-A1 Antimicrobial skin preparations containing organosilane quaternaries COATING SYSTEMS LABORATORIES, INC. (US) 2002-10-03 US claimed
WO-2000072850-A1 FOOT CARE COMPOSITIONS CONTAINING QUATERNARY AMMONIUM ORGANOSILANES COATING SYSTEMS LABORATORIES, INC. (US) 2000-12-07 WO claimed
WO-2000054587-A1 ANTIMICROBIAL SKIN PREPARATIONS CONTAINING ORGANOSILANE QUATERNARIES COATING SYSTEMS LABORATORIES, INC. (US) 2000-09-21 WO claimed
WO-2026102303-A1 TREATMENT SYSTEMS FOR WOUND CARE Peterson science (US) 2026-05-15 WO disclosed
US-20260131047-A1 TREATMENT SYSTEMS FOR WOUND CARE Peterson science (US) 2026-05-14 US disclosed
WO-2025101843-A1 COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS PETERSON WILLIAM R (US) 2025-05-15 WO disclosed
US-6613755-B2 Disinfecting skin, hair or nails with water soluble compound such as 3-(trimethoxysilyl)propyloctadecyldimethyl ammonium chloride or 3-(trimethoxysilyl)propyldidecylmethyl ammonium chloride COATING SYSTEMS LABORATORIES, INC. 2003-09-02 US disclosed
US-20030021721-A1 Purification of air MICROGENIX LIMITED 2003-01-30 US disclosed
US-20020141959-A1 Antimicrobial skin preparations containing organosilane quaternaries COATING SYSTEMS LABORATORIES, INC. (US) 2002-10-03 US disclosed
WO-2000054587-A1 ANTIMICROBIAL SKIN PREPARATIONS CONTAINING ORGANOSILANE QUATERNARIES COATING SYSTEMS LABORATORIES, INC. (US) 2000-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050008613-A1 Antimicrobial quaternary ammonium organosilane coatings QARS1, GATD3, ACMSD LMNA 4686/4885
US-20260131047-A1 TREATMENT SYSTEMS FOR WOUND CARE CD44, IL33, CUTA LMNA 4195/4885
US-20160128333-A1 ANTIMICROBIAL QUATERNARY AMMONIUM ORGANOSILANE COATINGS QARS1, GATD3, ACMSD LMNA 4686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.